Profile
Company facts
- Exchange
- SHE
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- CNE100000KG1
- Market cap
- 13B
- P/E ratio
- 79.31
- Analyst target
- 70
- Dividend yield
- 0.0%
- Beta
- -0.29
About
About Inner Mongolia Furui Medical Science Co., Ltd
Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company also engages in the research and development and sales of diagnostic equipment and related medical services. It offers FibroScan series of liver fibrosis diagnostic instruments; FibroMeter series of blood test analysis tools for evaluating chronic liver disease; and FibroView data management software. It provides digital health management services; compound turtle shell softening liver tablets; and prescription drugs. The company was formerly known as Inner Mongolia FuRui Pharmaceutical Limited Liability Company. Inner Mongolia Furui Medical Science Co., Ltd. was founded in 1998 and is headquartered in Beijing, China.
Visit company website
5 years, 5 months ago
Inner Mongolia Furui Medical Science Co., Ltd is currently in a long term uptrend where the price is trading 20.8% above its 200 day moving average.
From a valuation standpoint, the stock is 76.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.3.
Inner Mongolia Furui Medical Science Co., Ltd's total revenue sank by 23.1% to $198M since the same quarter in the previous year.
Its net income has dropped by 20.9% to $15M since the same quarter in the previous year.
Finally, its free cash flow fell by 14.8% to $26M since the same quarter in the previous year.
Based on the above factors, Inner Mongolia Furui Medical Science Co., Ltd gets an overall score of 2/5.